ALK and non-small cell lung carcinoma: As treatment strategies for patients with ALK‐rearrangement non‐small‐cell lung cancer (NSCLC) are constantly evolving and given the continuing concerns regarding ALK‐TKI‐induced pneumonitis, we aimed to update this previous meta‐analysis.